| GEN |
Report |
Total Revenue (Q1 FY27) |
BEAT |
pred ~$1,330M vs. cons $1,314M (+1.2%) |
MEDIUM |
| GEN |
Report |
MoneyLion Revenue (Q1 FY27) |
BEAT |
pred ~$275M vs. cons $269M (+2.3%) |
MEDIUM |
| GEN |
Report |
EPS - Diluted Operating (Q1 FY27) |
BEAT |
pred ~$0.70 vs. cons $0.690 (+1.4%) |
MEDIUM |
| GEN |
Guide |
Revenue (Q2 FY27) |
UNCHANGED |
guide ~$1.340-1.365B vs. cons $1.350B (~flat) |
MEDIUM |
| GEN |
Guide |
Revenue (FY27) |
UNCHANGED |
guide reaffirm $5.325-5.425B vs. cons $5.378B (~flat) |
MEDIUM |
| GEN |
Guide |
EPS (FY27) |
UNCHANGED |
guide reaffirm $2.85-2.95 vs. cons $2.893 (~flat) |
MEDIUM |
| GEN |
Return |
Day-1 residual (stock − beta × S&P 500) |
+4.5% |
— |
MEDIUM |
| GEN |
Return |
5-day cumulative residual |
+6.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — modest estimate revisions as sell-side marks up Q1 actuals; partial lift to Q2-Q4 given FY guide reaffirmation rather than raise |
MEDIUM |